Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab non-inferiority study in high-need versus low-need chronic plaque psoriasis patients
2005-001243-28Phase 3Completed
- Sponsor
- Essex Bio-Technology Limited
- Start
- May 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of infliximab in plaque psoriasis (2 arms), sponsored by Essex Bio-Technology Limited. Started May 2005; status: completed.
02
Drugs
infliximab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2005-001243-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001243-28.